Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a $10.2 billion valuation.
The new cash infusion came from TWG Global, a holding company jointly led by Mark Walter and Thomas Tull.
The Dallas-based startup, which launched in 2021, plans to use the money to continue to advance its genetic engineering technologies, as well as grow its software and hardware solutions for applications involved with de-extinction, conservation and human health care.
The company said bringing back extinct animals could allow for a better understanding of evolutionary change in other species, and that genetic engineering applications also will help enhance food production and reduce environmental impact.
Colossal has said it has generated “ancient genomes” for some thylacines, an extinct tiger.
“Our recent successes in creating the technologies necessary for our end-to-end de-extinction toolkit have been met with enthusiasm by the investor community,” said CEO and co-founder of Colossal Ben Lamm in a statement. “This funding will grow our team, support new technology development, expand our de-extinction species list, while continuing to allow us to carry forth our mission to make extinction a thing of the past.”
A couple years ago
It was January 2023 when Colossal Biosciences raised a $150 million Series B to further its de-extinction platform that could bring back the dodo bird and the woolly mammoth. The round was led by Tull’s US Innovative Technology Fund, and included participation from Breyer Capital, WestRiver Group, Animal Capital, In-Q-Tel, Animoca Brands, Peak 6, Bold Capital, Jazz Venture Partners and others.
Since launching in September 2021, Colossal has raised $435 million, per the company.
Related reading:
Illustration: Dom Guzman
Stay up to date with recent funding rounds, acquisitions, and more with the
Crunchbase Daily.
Source link
#DeExtinction #Startup #Colossal #Biosciences #Hits #Decacorn #Status #200M #Raise
